Results of the SORAYA study show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Newswise — BOSTON – In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate…

Read more Results of the SORAYA study show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer